AMAR DHAND, MD, DPhil, Divisions of Hospital Neurology and Stroke and Cerebrovascular Disease. He has expertise in stroke syndromes, rehabilitation medicine, neuropathic itch, diagnostic reasoning, and social interactions in medicine. He has built novel patient education tools such as the NeuroBoard, a dry erase map of the brain. His research concerns social networks and health outcomes in neurology patients. His goal is to understand and harness social networks to improve patients’ lives.
ROSE DU, MD, Ph.D., Director of Cerebrovascular Surgery, is a fellowship-trained neurosurgeon in Cerebrovascular and Skull Base Surgery. Dr. Du is an expert cerebrovascular neurosurgeon and specializes in open treatment options. Dr. Du conducts clinical research on cerebral aneurysms, cerebral and spinal arteriovenous malformations (AVMs), cerebral and spinal dural arteriovenous fistulas, moyamoya, cavernous malformations, carotid stenosis, stroke, cerebral aneurysms, and cerebral vasospasm.
STEVEN K. FESKE, MD, Medical Director, Stroke and Cerebrovascular Center, is an expert in stroke neurology and innovative medical therapy for stroke. Dr. Feske is currently collaborating in the investigation of a mechanism of cell signaling, thought to mediate inflammatory responses during stroke evolution.
KAI U. FRERICHS, MD, Director of Endovascular Neurosurgery, is a dual fellowship-trained neurosurgeon specializing in endovascular treatment options. Dr. Frerichs uses leading multimodality approaches for cerebrovascular disease treatment, including coil embolization of cerebral aneurysms, intra-arterial interventions for clot thrombolysis and removal in acute stroke, carotid and intracranial stenting and angioplasty, and cerebral and spinal AVM. Dr. Frerichs’ research focus includes the development of novel neuroprotective strategies for stroke and neurotrauma.
WILLIAM B. GORMLEY, MD, MPH, MBA, Director of Neurosurgical Critical Care, is a fellowship-trained neurosurgeon specializing in critical care neurosurgery. One of Dr. Gormley’s areas of research focuses on the analysis of neurosurgical outcomes.
GALEN V. HENDERSON, MD, Medical Director of the Neuroscience Intensive Care Unit at Brigham and Women’s Hospital, is currently evaluating the incidence, management, and outcome of non-aneurysmal subarachnoid hemorrhage, as well as mechanical retrieval for acute ischemic stroke.
NIRAV J. PATEL, MD, FAANS, Neurosurgeon at the Center for Cerebrovascular Diseases and our Endovascular/Interventional Neuroradiology Service. Dr. Patel has extensive expertise in a wide range of innovative techniques to treat aneurysms, stroke, and brain tumors.
ALI AZIZ-SULTAN, MD, Chief of Vascular/Endovascular Neurosurgery, is a dual fellowship-trained neurosurgeon specializing in both open and endovascular approaches to cerebrovascular conditions and has extensive expertise in a wide range of innovative techniques to treat aneurysms, stroke and brain tumors. Examples include the use of flow diverter stents to address aneurysms, stent retrievers to achieve high recanalization rates in stroke patients, and chemoembolization to treat brain tumors.
HENRIKAS VAITKEVICUS, MD, Divisions of neurocritical care and hospital neurology. He is interested in multidisciplinary care of advance neurocritical care disorders including cerebrovascular, refractory epilepsy and neuroimmunology. He has a particular interest in management of fulminant neuroimmunologic disorders and complications of immunologic oncological therapies.
For over a century, a leader in patient care, medical education and research, with expertise in virtually every specialty of medicine and surgery.